Global Drugs for Solid Tumors Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 Drugs for Solid Tumors Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Drugs for Solid Tumors
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Drugs for Solid Tumors Market by Type

• 3.1 By Type
  • 3.1.1 Small Molecules
  • 3.1.2 Biologics
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Drugs for Solid Tumors Hoffmann-La Roche (Company Profile, Sales Data etc.)

• 4.2 Novartis (Company Profile, Sales Data etc.)
• 4.3 Celgene (Company Profile, Sales Data etc.)
• 4.4 Johnson & Johnson (Company Profile, Sales Data etc.)
• 4.5 Pfizer (Company Profile, Sales Data etc.)
• 4.6 BMS (Company Profile, Sales Data etc.)
• 4.7 Eli Lilly (Company Profile, Sales Data etc.)
• 4.8 GSK (Company Profile, Sales Data etc.)
• 4.9 Merck (Company Profile, Sales Data etc.)
• 4.10 Sanofi (Company Profile, Sales Data etc.)
• 4.11 AbbVie (Company Profile, Sales Data etc.)
• 4.12 AstraZeneca (Company Profile, Sales Data etc.)
• 4.13 Bayer (Company Profile, Sales Data etc.)
• 4.14 Biogen (Company Profile, Sales Data etc.)
• 4.15 Boehringer Ingelheim (Company Profile, Sales Data etc.)
• 4.16 Boston Biomedical (Company Profile, Sales Data etc.)
• 4.17 Daiichi Sankyo (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospitals
  • 6.1.2 Demand in Clinics
  • 6.1.3 Demand in Academic and Research Institutes
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Drugs for Solid Tumors

Table Application Segment of Drugs for Solid Tumors

Table Global Drugs for Solid Tumors Market 2013-2024, by Application, in USD Million

Table Major Company List of Small Molecules

Table Major Company List of Biologics

Table Global Drugs for Solid Tumors Market 2013-2018, by Type, in USD Million

Table Global Drugs for Solid Tumors Market 2013-2018, by Type, in Volume

Table Global Drugs for Solid Tumors Market Forecast 2019-2024, by Type, in USD Million

Table Global Drugs for Solid Tumors Market Forecast 2019-2024, by Type, in Volume

Table Hoffmann-La Roche Overview List

Table Drugs for Solid Tumors Business Operation of Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Drugs for Solid Tumors Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celgene Overview List

Table Drugs for Solid Tumors Business Operation of Celgene (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Drugs for Solid Tumors Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Drugs for Solid Tumors Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BMS Overview List

Table Drugs for Solid Tumors Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Drugs for Solid Tumors Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GSK Overview List

Table Drugs for Solid Tumors Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Drugs for Solid Tumors Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Drugs for Solid Tumors Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbbVie Overview List

Table Drugs for Solid Tumors Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Drugs for Solid Tumors Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayer Overview List

Table Drugs for Solid Tumors Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biogen Overview List

Table Drugs for Solid Tumors Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim Overview List

Table Drugs for Solid Tumors Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boston Biomedical Overview List

Table Drugs for Solid Tumors Business Operation of Boston Biomedical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo Overview List

Table Drugs for Solid Tumors Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Drugs for Solid Tumors Sales Revenue 2013-2018, by Company, in USD Million

Table Global Drugs for Solid Tumors Sales Revenue Share, by Company, in USD Million

Table Global Drugs for Solid Tumors Sales Volume 2013-2018, by Company, in Volume

Table Global Drugs for Solid Tumors Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Drugs for Solid Tumors Demand Forecast 2019-2024, by Application, in USD Million

Table Drugs for Solid Tumors Demand Forecast 2019-2024, by Application, in Volume

Table Drugs for Solid Tumors Production 2013-2018, by Region, in USD Million

Table Drugs for Solid Tumors Production 2013-2018, by Region, in Volume

Table Global Drugs for Solid Tumors Market 2013-2018, by Region, in USD Million

Table Global Drugs for Solid Tumors Market Share 2013-2018, by Region, in USD Million

Table Global Drugs for Solid Tumors Market 2013-2018, by Region, in Volume

Table Global Drugs for Solid Tumors Market Share 2013-2018, by Region, in Volume

Table North America Drugs for Solid Tumors Market Size 2013-2018, by Country, in USD Million

Table North America Drugs for Solid Tumors Market Size 2013-2018, by Country, in Volume

Table Europe Drugs for Solid Tumors Market Size 2013-2018, by Country, in USD Million

Table Europe Drugs for Solid Tumors Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Drugs for Solid Tumors Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Drugs for Solid Tumors Market Size 2013-2018, by Country, in Volume

Table South America Drugs for Solid Tumors Market Size 2013-2018, by Country, in USD Million

Table South America Drugs for Solid Tumors Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Drugs for Solid Tumors Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Drugs for Solid Tumors Market Size 2013-2018, by Country, in Volume

Table Drugs for Solid Tumors Market Forecast 2019-2024, by Region, in USD Million

Table Drugs for Solid Tumors Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Drugs for Solid Tumors Market Growth 2013-2018, by Type, in USD Million

Figure Global Drugs for Solid Tumors Market Growth 2013-2018, by Type, in Volume

Figure North America Drugs for Solid Tumors Market Concentration, in 2018

Figure Europe Drugs for Solid Tumors Market Market Concentration, in 2018

Figure Asia-Pacific Drugs for Solid Tumors MMarket Concentration, in 2018

Figure South America Drugs for Solid Tumors Market Concentration, in 2018

Figure Middle East & Africa Drugs for Solid Tumors Market Concentration, in 2018

Figure Drugs for Solid Tumors Demand in Hospitals, 2013-2018, in USD Million

Figure Drugs for Solid Tumors Demand in Hospitals, 2013-2018, in Volume

Figure Drugs for Solid Tumors Demand in Clinics, 2013-2018, in USD Million

Figure Drugs for Solid Tumors Demand in Clinics, 2013-2018, in Volume

Figure Drugs for Solid Tumors Demand in Academic and Research Institutes, 2013-2018, in USD Million

Figure Drugs for Solid Tumors Demand in Academic and Research Institutes, 2013-2018, in Volume

Figure North America Drugs for Solid Tumors Market Size and Growth 2013-2018, in USD Million

Figure North America Drugs for Solid Tumors Market Size and Growth 2013-2018, in Volume

Figure Europe Drugs for Solid Tumors Market Size and Growth 2013-2018, in USD Million

Figure Europe Drugs for Solid Tumors Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Drugs for Solid Tumors Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Drugs for Solid Tumors Market Size and Growth 2013-2018, in Volume

Figure South America Drugs for Solid Tumors Market Size and Growth 2013-2018, in USD Million

Figure South America Drugs for Solid Tumors Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Drugs for Solid Tumors Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Drugs for Solid Tumors Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview